IQVIA (IQV) Tmuɣli n wazal
IQVIA Holdings
Ṛṛbem n lḥedd$269.78Yettwalemmaḍ 25 Sep 2026 19:59 UTC
Beddel-1.91%
Asnulfu n AI: IQV
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
IQVIA Holdings Inc. specializes in technology solutions and contract research and development. The company offers a range of solutions, including clinical trial strategy development, therapeutic research, and predictive and prescriptive analytics. IQVIA Holdings Inc. serves healthcare and biopharmaceutical organizations worldwide.
